$13.48
0.201.51%
After Hours: 4:00 PM EDT
Comments
Loading...
Capricor Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:CAPR | Benzinga
Capricor Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 12
EPS Estimate
$-0.350
Quarterly Revenue Estimate
$2.17M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$23.23M
Analyze the earnings history of Capricor Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CAPR | Capricor Therapeutics | -$0.31 | -$0.35 | — | — | $4.91M | $2.17M | — | — | 05/12/2025 | Get Alert |
| CAPR | Capricor Therapeutics | -$0.02 | -$0.31 | -$0.16 | 48.39% | $12.09M | $3.20M | $11.13M | 247.84% | 03/19/2025 | Get Alert |
| CAPR | Capricor Therapeutics | -$0.25 | -$0.36 | -$0.38 | -5.56% | $6.18M | $3.57M | $2.26M | -36.64% | 11/13/2024 | Get Alert |
| CAPR | Capricor Therapeutics | -$0.29 | -$0.36 | -$0.35 | 2.78% | $3.92M | $3.66M | $3.97M | 8.50% | 08/07/2024 | Get Alert |
| CAPR | Capricor Therapeutics | -$0.31 | -$0.11 | -$0.31 | -181.82% | $2.99M | $9.70M | $4.91M | -49.41% | 05/13/2024 | Get Alert |
| CAPR | Capricor Therapeutics | -$0.31 | -$0.09 | -$0.02 | 77.78% | $959.90K | $10.60M | $12.09M | 14.04% | 02/29/2024 | Get Alert |
| CAPR | Capricor Therapeutics | -$0.26 | -$0.29 | -$0.25 | 13.79% | $1.59M | $2.11M | $6.18M | 193.13% | 11/14/2023 | Get Alert |
| CAPR | Capricor Therapeutics | -$0.29 | -$0.35 | -$0.29 | 17.14% | $0.00 | $1.50M | $3.92M | 161.13% | 08/07/2023 | Get Alert |
| CAPR | Capricor Therapeutics | -$0.32 | -$0.32 | -$0.31 | 3.12% | $0.00 | $500.00K | $2.99M | 497.40% | 05/11/2023 | Get Alert |
| CAPR | Capricor Therapeutics | -$0.26 | -$0.33 | -$0.31 | 6.06% | $0.00 | — | $959.90K | — | 03/15/2023 | Get Alert |
| CAPR | Capricor Therapeutics | -$0.17 | -$0.29 | -$0.26 | 10.34% | $0.00 | $210.00K | $1.59M | 658.10% | 11/10/2022 | Get Alert |
| CAPR | Capricor Therapeutics | -$0.22 | — | -$0.29 | — | $204.08K | — | $0.00 | — | 08/10/2022 | Get Alert |
| CAPR | Capricor Therapeutics | -$0.23 | — | -$0.32 | — | $40.82K | — | $0.00 | — | 05/10/2022 | Get Alert |
| CAPR | Capricor Therapeutics | -$0.21 | -$0.19 | -$0.26 | -36.84% | $57.83K | — | $0.00 | — | 03/10/2022 | Get Alert |
| CAPR | Capricor Therapeutics | -$0.20 | -$0.22 | -$0.17 | 22.73% | $16.86K | $210.00K | $0.00 | -100.00% | 11/09/2021 | Get Alert |
| CAPR | Capricor Therapeutics | -$0.23 | -$0.23 | -$0.22 | 4.35% | $49.86K | $210.00K | $204.08K | -2.82% | 08/12/2021 | Get Alert |
| CAPR | Capricor Therapeutics | -$0.30 | — | -$0.23 | — | $185.69K | — | $40.82K | — | 05/13/2021 | Get Alert |
| CAPR | Capricor Therapeutics | -$0.34 | — | -$0.21 | — | $222.10K | $210.00K | $57.83K | -72.46% | 03/11/2021 | Get Alert |
| CAPR | Capricor Therapeutics | -$0.43 | -$0.37 | -$0.20 | 45.95% | $142.07K | $210.00K | $16.86K | -91.97% | 11/12/2020 | Get Alert |
| CAPR | Capricor Therapeutics | -$0.59 | -$0.34 | -$0.23 | 32.35% | $410.35K | $210.00K | $49.86K | -76.26% | 08/06/2020 | Get Alert |
| CAPR | Capricor Therapeutics | -$0.80 | -$0.33 | -$0.30 | 9.09% | $230.50K | $210.00K | $185.69K | -11.57% | 05/14/2020 | Get Alert |
Capricor Therapeutics (CAPR) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-19 | $-0.16 | $-0.31 | 48.4 % |
| Q3 | 2024-11-13 | $-0.38 | $-0.36 | -5.56 % |
| Q2 | 2024-08-07 | $-0.35 | $-0.36 | 2.78 % |
| Q1 | 2024-05-13 | $-0.31 | $-0.11 | -181.8 % |
Capricor Therapeutics (CAPR) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-19 | $11.13M | $3.20M | 247.8 % |
| Q3 | 2024-11-13 | $2.26M | $3.57M | -36.6 % |
| Q2 | 2024-08-07 | $3.97M | $3.66M | 8.50 % |
| Q1 | 2024-05-13 | $4.91M | $9.70M | -49.4 % |
FAQ
When is Capricor Therapeutics (NASDAQ:CAPR) reporting earnings?
Capricor Therapeutics (CAPR) is scheduled to report earnings on May 12, 2025. The last reported earnings were for reported on March 19, 2025 for Q4.
What were the latest earnings per share (EPS) for Capricor Therapeutics (NASDAQ:CAPR)?
The Actual EPS was $-0.16, which beat the estimate of $-0.31.
What were Capricor Therapeutics’s (NASDAQ:CAPR) revenues?
The Actual Revenue was $11.1M, which beat the estimate of $3.2M.
Browse earnings estimates, EPS, and revenue on all stocks.